What happens when filler is dissolved with hyaluronidase?

What hyaluronidase is

Hyaluronidase is an enzyme that breaks the bonds holding hyaluronic acid together. Hyaluronic acid is part of the normal tissue around cells, and the enzyme’s approved medical role is to loosen that tissue briefly so that other injected fluids and drugs spread and absorb more easily. Hyaluronic acid filler is the same molecule, cross-linked into a gel so that it lasts. Injected into or around the gel, hyaluronidase breaks it down, and the body clears what is left.

That is the reason hyaluronic acid filler is described as reversible, and the reason any practice that injects it keeps hyaluronidase on hand. It is a prescription drug. In Arizona, a registered nurse injects it only on the order of a delegating prescriber, after the patient has been examined.

Which products exist

Several hyaluronidase products are approved by the FDA. A 2024 review in JMIR Dermatology lists four: Hylenex, made from human hyaluronidase by recombinant technology; Vitrase, purified from sheep (ovine) tissue; and Amphadase and Hydase, both from cattle (bovine) tissue. The Hylenex label describes it as produced in genetically engineered Chinese hamster ovary cells, and the Vitrase label describes it as purified ovine testicular hyaluronidase. Compounding pharmacies also prepare hyaluronidase, and the guidelines treat those preparations separately when they discuss allergy.

None of these products is approved for dissolving filler. the Hylenex label lists three uses: as an adjuvant to increase the dispersion and absorption of other injected drugs, for subcutaneous fluid administration to achieve hydration, and in subcutaneous urography; dissolving filler is not among them ^{(source, verified Nov 2026)}. Vitrase carries the same three indications. a 2024 review in JMIR Dermatology states that hyaluronidase is used off-label in aesthetics ^{(source, verified Nov 2026)}, and the consent conversation should say so. Off-label means the evidence for this use comes from published studies and guidelines rather than from the label.

Why filler is dissolved

Most dissolving is elective, done to correct or remove a result:

• Migration. Filler can move from where it was placed, leaving, for example, a soft fullness above the lip border or an uneven outline.
• Lumps and nodules. Filler that has not settled evenly can leave a lump that can be felt or seen.
• Overfilling. An area that looks heavier or larger than intended, either straight away or as filler accumulates over repeated treatments.
• The Tyndall effect. Filler placed too close to the surface can give the skin a bluish tint, and dissolving it is the first treatment.
• Dissatisfaction. Sometimes the result is technically fine and the person simply does not like it. That is a legitimate reason too.

The other use is urgent. If filler blocks an artery, hyaluronidase in much larger doses is the treatment with direct evidence behind it. That emergency protocol is covered in what a vascular occlusion is and how it is treated and is not repeated here.

How a dissolving appointment goes

It starts as a consultation, not an injection. For a new patient in Arizona that includes a Good Faith Exam with the delegating prescriber, who decides whether hyaluronidase is appropriate and orders it. The questions that matter most are which filler was used, where and when; any allergy history, including to bee or wasp stings; current medicines; and any infection or inflammation in the area.

Allergy is the main reason for caution. The CMAC guideline flags allergy to bee and wasp venom as a significant cross-reactivity risk. For planned, non-urgent treatment, some practitioners do a small test injection first and wait to see whether the skin reacts. for ovine, bovine or compounded hyaluronidase, the CMAC guideline recommends an intradermal test of 15 units on the inner forearm, examined after 20 minutes, and notes that redness can also appear some hours later ^{(source, verified Nov 2026)}. The JMIR Dermatology review notes that no pretest is required for recombinant hyaluronidase but that one may be considered for ovine, bovine or compounded products. In an emergency, testing is skipped because the delay is the greater risk.

The treatment itself is a series of small injections into the filler. The enzyme acts quickly. the same review describes an immediate effect, a half-life of about 2 minutes and a duration of action of 24 to 48 hours ^{(source, verified Nov 2026)}. in one small randomized trial included in a 2022 scoping review, most of the visible change came between 30 minutes and 3 hours after injection, with gradual further breakdown through week 2 ^{(source, verified Nov 2026)}. So some change is often visible the same day, but the area is swollen from the injections, and the result is judged later.

How much is used

There is no standard dose. The amount depends on the product being dissolved, how much of it there is, where it sits, and the hyaluronidase preparation used. The figures below are what the literature reports, not a recipe.

Two things follow. First, the ranges are wide because the evidence is thin: the scoping review’s own authors describe the trials as small and hard to compare. Second, different fillers resist the enzyme differently. The JMIR Dermatology review cites a study in which Juvéderm Voluma needed higher doses than Restylane-L and Juvéderm Ultra, and another in which Belotero broke down fastest. Knowing the product helps the prescriber plan, and it is one reason the review suggests starting with a low dose and reassessing.

Repeat sessions

One session is not always enough. in non-emergency use, the CMAC guideline says the patient can be assessed after 48 hours and the treatment repeated if necessary ^{(source, verified Nov 2026)}. Lumps, older filler and firmer volumizing products are the usual reasons for a second round. The point of waiting between sessions is the same as in the first: to see the result once the swelling from the injections has gone, so that no more enzyme is used than the area needs.

Your own hyaluronic acid

Hyaluronidase does not distinguish filler from the hyaluronic acid your tissue makes, so it also breaks down some of the latter where it is injected. This is temporary. the CMAC guideline states that the body restores its own hyaluronic acid in 15 to 20 hours ^{(source, verified Nov 2026)}. The Vitrase label reports a similar recovery for the skin’s barrier: in human data in the Vitrase label, the skin barrier opened by intradermal hyaluronidase was only partly restored at 24 hours and fully restored in all treated areas at 48 hours ^{(source, verified Nov 2026)}. The JMIR Dermatology review concludes that there are no harmful long-term effects on skin quality. The result is worth judging once the swelling has settled.

Swelling afterwards

Expect some redness and swelling where the injections went in. the CMAC guideline describes the expected injection-site reaction as redness and some swelling that subsides within 24 hours ^{(source, verified Nov 2026)}. The JMIR Dermatology review lists itching, a burning sensation, swelling and redness as the usual local effects, and notes that bruising can spread where the skin is thin. Lips swell readily, so a dissolved lip can look puffy for a day or two. How long lip filler swelling lasts describes the normal course and the signs that are not normal.

Swelling that keeps growing, spreads beyond the treated area, or comes with hives, itching elsewhere, or any difficulty breathing or swallowing is not the expected reaction and needs a call at once, or emergency care for the breathing symptoms.

When re-filling is reasonable

Dissolving is sometimes the first step towards a different result rather than the end of treatment. The question is when the area is ready. the CMAC guideline recommends waiting a minimum of two weeks, until the swelling has settled, before treating the area with filler again, and longer if swelling after the procedure is significant ^{(source, verified Nov 2026)}. Waiting also lets the prescriber and injector see what is actually there, without the old filler or the swelling, before deciding whether to add anything at all.

Whether to re-fill, and how, is a decision for a consultation. If the reason for dissolving was migration or overfilling, the plan for any new treatment should explain what will be done differently.

Risks and limits

• Allergy. the Vitrase label reports allergic reactions, such as hives or angioedema, in less than 0.1% of patients receiving hyaluronidase ^{(source, verified Nov 2026)}. the CMAC guideline describes the true risk of anaphylaxis as extremely small, lower than the often-quoted 0.1 percent ^{(source, verified Nov 2026)}. The JMIR Dermatology review says epinephrine (adrenaline) must be available at the bedside. Known allergy to hyaluronidase is a contraindication on the labels.
• Infection. The Vitrase label warns against injecting hyaluronidase into or around an infected or acutely inflamed area, because it can help the infection spread.
• Medicines. The Vitrase label notes that large doses of salicylates such as aspirin, cortisone, estrogens or antihistamines can make tissue partly resistant, so more enzyme may be needed, and that furosemide, benzodiazepines and phenytoin are incompatible with it.
• Repeated exposure. The label also notes that the enzyme is antigenic: repeated injections of relatively large amounts may lead to neutralizing antibodies.
• Incomplete dissolution. Some fillers need more enzyme or more sessions than others, and the outcome cannot be promised in advance.
• Other filler materials. Hyaluronidase acts on hyaluronic acid only. The JMIR Dermatology review names poly-L-lactic acid, calcium hydroxylapatite and polymethylmethacrylate as fillers it cannot dissolve, and those are managed differently. If you do not know what was injected, find out before planning to dissolve it.

Why the consultation and the prescriber come first

Dissolving filler looks simple and is not trivial. It is a prescription drug used off-label, with an allergy risk, in an area where something has already gone differently from what was hoped. Under the Arizona Board of Nursing’s rules, Tanya practices under a delegating prescriber, a new patient has a Good Faith Exam before treatment, and hyaluronidase is given on that prescriber’s order. That sequence is what makes it possible to check the history, the medicines and the product before any injection, and to say honestly whether dissolving is likely to help. It is also why no one should be promised a result, or a date for re-filling, before they have been seen. The filler safety guide sets out the wider picture.